PART III: PLANNING AND EXECUTING SUPPLY CHAIN CHANGE.
CHAPTER 14 IMPROVEMENT IN PHARMACEUTICALS.
14.1 Where are we now?
14.2 Subsequent developments since inception.
14.3 A Blueprint for Quality by Design (QbD).
CHAPTER 15 EXEMPLAR THINKING IN ORGANISATIONAL IMPROVEMENT.
15.1 Where are we now?
15.2 What is meant by 'Exemplar'?
15.3 A dialogue on exemplar improvement.
CHAPTER 16 BUILDING A FOUNDATION FOR SUSTAINABLE CHANGE.
16.1 Focus on the individual.
16.2 Individuals as leaders.
16.3 Individuals as motivators and the motivated.
16.4 Individuals as group members.
16.5 Individuals as participants in cultural change.
16.6 CASE STUDY MILES LTD., BRIDGEND, GLAMORGAN.
CHAPTER 17 A CURE FOR THE PHARMACETICAL SUPPLY CHAIN.
17.1 What is the disease state?
17.2 What is the label claim for the Medicine?
17.3 What will life hold without the medicine?
17.4 What is this 'better way' to develop drugs?
17.5 Full scale production of drugs.
17.6 What are the barriers to change?
17.7 What are the potential benefits of change?
17.8 Defining the art of the possible.
17.9 Concluding message.
OBNB doesn't sell books, but you may be able to find a copy at one of these websites:
Supply chain management in the drug industry : delivering patient value for pharmaceuticals and biologics by Hedley Rees. ISBN 9780470555170. Published by Wiley-Blackwell in 2011. Publication and catalogue information, links to buy online and reader comments.
